Patent intelligence · US
US 12419942
Use of the Salmonella spp type III secretion proteins as a protective vaccination
Use of the Salmonella spp type III secretion proteins as a protective vaccination
Patent details — US 12419942
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 23, 2025
- Expiration
- Sep 18, 2045
- Claims
- 4
- CPC classes
- A61K, A61K2039/543, A61K2039/552, A61K2039/55505
Quick answer
US 12419942 (Use of the Salmonella spp type III secretion proteins as a protective vaccination) is held by The Board of Regents for Oklahoma State University. Status: granted. Granted Sep 23, 2025. Expires Sep 18, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 4
- CPC classes
- A61K, A61K2039/543, A61K2039/552, A61K2039/55505, A61K2039/55544, A61K2039/55572
More from The Board of Regents for Oklahoma State University
Related pharmaceutical patents in our USPTO index.
-
US 12428463
Chimeric antigen receptors targeting abnormal glycobiology
granted -
US 12427148
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted -
US 12428416
ERK inhibitors and uses thereof
granted -
US 12427151
Compositions and method of treating cancer
granted -
US 12427197
Methods of producing cobalt nanoparticles and hollow metal nanospheres
granted -
US 12428489
Human PD-L2 antibodies and methods of use therefor
granted -
US 12427155
Treatment for tau-related diseases
granted -
US 12428455
Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells
granted
Frequently asked questions
What is US patent 12419942?
US 12419942 (Use of the Salmonella spp type III secretion proteins as a protective vaccination) is held by The Board of Regents for Oklahoma State University. Status: granted. Granted Sep 23, 2025. Expires Sep 18, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12419942?
The Board of Regents for Oklahoma State University is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8,292 pharmaceutical patents for this assignee.
When does US 12419942 expire?
Our index shows an expiration date of Sep 18, 2045 (19 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.